(Q48223990)

9 February 2018

title

Plasma pharmacokinetics and tissue distribution of paclitaxel in CD2F1 mice. (English)

1 reference

9 February 2018

1 reference

1 reference

J L Eiseman

1

1 reference

9 February 2018

N D Eddington

2

1 reference

9 February 2018

J Leslie

3

1 reference

9 February 2018

C MacAuley

4

1 reference

9 February 2018

D L Sentz

5

1 reference

9 February 2018

M Zuhowski

6

1 reference

9 February 2018

J M Kujawa

7

1 reference

9 February 2018

D Young

8

1 reference

9 February 2018

M J Egorin

9

1 reference

9 February 2018

publication date

1 January 1994

1 reference

9 February 2018

Cancer Chemotherapy and Pharmacology

published in

1 reference

9 February 2018

volume

34

1 reference

9 February 2018

issue

6

1 reference

9 February 2018

page(s)

465-471

1 reference

9 February 2018

Taxol: a novel investigational antimicrotubule agent

cites work

1 reference

12 December 2020

Stability problems with taxol in mouse plasma during analysis by liquid chromatography

1 reference

12 December 2020

A program package for simulation and parameter estimation in pharmacokinetic systems

1 reference

12 December 2020

Phase I trial of taxol given as a 3-hour infusion every 21 days

1 reference

12 December 2020

Phase I clinical and pharmacokinetic study of taxol.

1 reference

12 December 2020

Phase I and pharmacodynamic study of taxol in refractory acute leukemias.

1 reference

12 December 2020

Sequences of taxol and cisplatin: a phase I and pharmacologic study

1 reference

12 December 2020

Phase I trial of taxol in patients with advanced cancer

1 reference

12 December 2020

Taxol-induced polymerization of purified tubulin. Mechanism of action

1 reference

12 December 2020

Phase II study of taxol in patients with untreated advanced non-small-cell lung cancer

1 reference

12 December 2020

Potential roles for preclinical pharmacology in phase I clinical trials

1 reference

12 December 2020

Phase I trial of taxol given as a 24-hour infusion every 21 days: responses observed in metastatic melanoma.

1 reference

12 December 2020

A phase II trial of taxol in metastatic melanoma

1 reference

12 December 2020

Taxol: an antimitotic agent with a new mechanism of action

1 reference

12 December 2020

Taxol metabolism. Isolation and identification of three major metabolites of taxol in rat bile

1 reference

12 December 2020

LAGRAN program for area and moments in pharmacokinetic analysis.

1 reference

12 December 2020

Phase I and pharmacologic study of paclitaxel and cisplatin with granulocyte colony-stimulating factor: neuromuscular toxicity is dose-limiting

1 reference

12 December 2020

Phase I study of taxol and granulocyte colony-stimulating factor in patients with refractory ovarian cancer

1 reference

12 December 2020

Effect of cimetidine, probenecid, and ketoconazole on the distribution, biliary secretion, and metabolism of [3H]taxol in the Sprague-Dawley rat.

1 reference

12 December 2020

Pharmacologically guided phase I clinical trials based upon preclinical drug development

1 reference

12 December 2020

Steady-state plasma concentrations and effects of taxol for a 250 mg/m2 dose in combination with granulocyte-colony stimulating factor in patients with ovarian cancer

1 reference

12 December 2020

Phase II study of taxol, merbarone, and piroxantrone in stage IV non-small-cell lung cancer: The Eastern Cooperative Oncology Group Results

1 reference

12 December 2020

Antineoplastic Agents from Plants

1 reference

12 December 2020

Phase II Trial of Taxol, an Active Drug in the Treatment of Metastatic Breast Cancer

1 reference

12 December 2020

Phase I trial of intraperitoneal taxol: a Gynecoloic Oncology Group study

1 reference

12 December 2020

Phase II study and long-term follow-up of patients treated with taxol for advanced ovarian adenocarcinoma

1 reference

12 December 2020

A comparison of numerical integrating algorithms by trapezoidal, Lagrange, and spline approximation

1 reference

12 December 2020

Promotion of microtubule assembly in vitro by taxol

1 reference

12 December 2020

Paclitaxel and recombinant human granulocyte colony-stimulating factor as initial chemotherapy for metastatic breast cancer

1 reference

12 December 2020

Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia

1 reference

12 December 2020

Taxol: a unique antineoplastic agent with significant activity in advanced ovarian epithelial neoplasms

1 reference

12 December 2020

Identifiers

DOI

10.1007/S002800050174

1 reference

9 February 2018

PubMed ID

7923556

1 reference

9 February 2018